Nikita V. Baclig

ORCID: 0000-0001-5001-9699
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neutropenia and Cancer Infections
  • Acute Myeloid Leukemia Research
  • Childhood Cancer Survivors' Quality of Life
  • Hematopoietic Stem Cell Transplantation
  • Cancer Immunotherapy and Biomarkers
  • Economic and Financial Impacts of Cancer
  • Renal cell carcinoma treatment
  • Hematological disorders and diagnostics
  • Palliative Care and End-of-Life Issues
  • Acute Lymphoblastic Leukemia research
  • Family Support in Illness
  • Cancer-related cognitive impairment studies
  • Esophageal Cancer Research and Treatment
  • CAR-T cell therapy research
  • Cardiac, Anesthesia and Surgical Outcomes
  • Hemoglobinopathies and Related Disorders
  • HER2/EGFR in Cancer Research
  • Mycobacterium research and diagnosis
  • Cancer survivorship and care
  • Lymphoma Diagnosis and Treatment
  • Breast Cancer Treatment Studies
  • Global Cancer Incidence and Screening
  • COVID-19 and healthcare impacts
  • Patient Safety and Medication Errors
  • Ethics in medical practice

University of California, Los Angeles
2021-2025

Fielding Graduate University
2024

University of Washington
2018-2020

Seattle University
2019

Adolescent and young adult cancer survivors experience mental health challenges, yet little is known about the evolution of these difficulties. This study explored symptoms utilization among long-term adolescent survivors.

10.1093/jncics/pkad098 article EN cc-by JNCI Cancer Spectrum 2023-10-31

e24086 Background: Palliative care (PC) is a vital tool in the treatment of patients with metastatic cancer, yet its role renal cell cancer (mRCC) poorly defined. These individuals are increasingly treated immune checkpoint inhibitor-based combination therapies (ICT). While this approach confers survival advantage, it comes additional toxicity that may necessitate PC. Yet, little known about how ICT impacts PC use for mRCC patients. Here we present real-world data from single center an...

10.1200/jco.2024.42.16_suppl.e24086 article EN Journal of Clinical Oncology 2024-06-01

Prior to the development of new cancer technologies, metastatic Renal Cell Carcinoma (mRCC) had a poor prognosis. Fortunately, advances in treatment are allowing growing population patients live with advanced or mRCC. While quality life has been an area investigation this as treatments advance, relatively little is known about specific survivorship needs experienced by these modern era. Using five domains defined National Cancer Institute, narrative review explores literature addressing...

10.52733/kcj22n1-r1 article EN Kidney Cancer Journal 2024-03-14

Adverse events can take an emotional toll on physicians, which, left unprocessed, have negative impacts well-being, including burnout and depression. Peer support help mitigate these effects. Structured programs train physicians to aid colleagues in processing work-related experiences emotions such as guilt self-doubt. Although are common for faculty, peer resident has not been adequately addressed, few described the literature. Residency is a vulnerable time of professional identity...

10.34197/ats-scholar.2023-0011ps article EN cc-by-nc-nd ATS Scholar 2023-09-06

Purpose of review Breast cancer (BC) is the most common among women in United States and second leading cause death. BC research, diagnostics, drug development, expansion therapies for novel indications advances so rapidly that treatment standards change month-by-month. Herein we discuss notable advancements past year hormone receptor positive (HR+) HER2 negative (HER2−) BC. Recent findings Radiolabeled estradiol imaging circulating tumor DNA (ctDNA) have changed our approach to metastatic...

10.1097/gco.0000000000000925 article EN Current Opinion in Obstetrics & Gynecology 2023-12-07

229 Background: Adolescent and Young Adult (AYA) cancer survivors experience psychological sequelae, yet causal pathways between AYA cancer, mood disorders, mental healthcare remain unclear. The 2019 National Health Interview Survey (NHIS) applies the Patient Questionnaire-8 item (PHQ8) Generalized Anxiety Disorder-7 (GAD7), providing validated evaluation of health (MH) in a national sample. We investigated how history affects MH symptoms care utilization. Methods: Descriptive statistics...

10.1200/jco.2022.40.28_suppl.229 article EN Journal of Clinical Oncology 2022-09-30

e18747 Background: Despite the deleterious effects of systemic cancer treatment on fertility, many young adult patients do not receive fertility preservation. Historically, oncofertility was discussed by medical oncologist (MO), but an increasing advanced practice provider (APP) oncology workforce provides opportunities for quality improvement (QI) in care. To identify levers QI interventions, we explored how beliefs, knowledge, and MOs differ from APPs. Methods: APPs working inpatient,...

10.1200/jco.2023.41.16_suppl.e18747 article EN Journal of Clinical Oncology 2023-06-01

6532 Background: Adults with acute myeloid leukemia (AML) typically remain hospitalized after induction chemotherapy for the duration of pancytopenia. Several studies have suggested that outpatient management following completion is safe and associated lower resource utilization. This has become standard practice at our institution if logistics allow. Here, we examine outcomes adults ≥18 years age newly-diagnosed AML (acute promyelocytic excluded) or high-grade neoplasms (i.e. ≥10% blasts)...

10.1200/jco.2018.36.15_suppl.6532 article EN Journal of Clinical Oncology 2018-05-20

Background: While adults with AML typically remain hospitalized after completion of intensive induction therapy until blood count recovery, early hospital discharge (EHD) has become routine at our center institutional studies suggested safety and reduction resource utilization. These used strict medical logistic criteria to identify appropriate EHD patients but this practice since been applied a broader patient population. Aims: To investigate the utilization over 4-year period prospective...

10.1097/01.hs9.0000559224.27449.a4 article EN cc-by-nc-nd HemaSphere 2019-06-01
Coming Soon ...